Mice expressing a human KATP channel mutation have altered channel ATP sensitivity but no cardiac abnormalities

AIMS/HYPOTHESIS: Patients with severe gain-of-function mutations in the Kir6.2 subunit of the ATP-sensitive potassium (K(ATP)) channel, have neonatal diabetes, muscle hypotonia and mental and motor developmental delay-a condition known as iDEND syndrome. However, despite the fact that Kir6.2 forms the pore of the cardiac K(ATP) channel, patients show no obvious cardiac symptoms. The aim of this project was to use a mouse model of iDEND syndrome to determine whether iDEND mutations affect cardiac function and cardiac K(ATP) channel ATP sensitivity. METHODS: We performed patch-clamp and in vivo cine-MRI studies on mice in which the most common iDEND mutation (Kir6.2-V59M) was targeted to cardiac muscle using Cre-lox technology (m-V59M mice). RESULTS: Patch-clamp studies of isolated cardiac myocytes revealed a markedly reduced K(ATP) channel sensitivity to MgATP inhibition in m-V59M mice (IC(50) 62 μmol/l compared with 13 μmol/l for littermate controls). In vivo cine-MRI revealed there were no gross morphological differences and no differences in heart rate, end diastolic volume, end systolic volume, stroke volume, ejection fraction, cardiac output or wall thickening between m-V59M and control hearts, either under resting conditions or under dobutamine stress. CONCLUSIONS/INTERPRETATION: The common iDEND mutation Kir6.2-V59M decreases ATP block of cardiac K(ATP) channels but was without obvious effect on heart function, suggesting that metabolic changes fail to open the mutated channel to an extent that affects function (at least in the absence of ischaemia). This may have implications for the choice of sulfonylurea used to treat neonatal diabetes

Proportionate vs disproportionate distribution of wealth of two individuals in a tempered Paretian ensemble

We study the distribution P(\omega) of the random variable \omega = x_1/(x_1 + x_2), where x_1 and x_2 are the wealths of two individuals selected at random from the same tempered Paretian ensemble characterized by the distribution \Psi(x) \sim \phi(x)/x^{1 + \alpha}, where \alpha > 0 is the Pareto index and $\phi(x)$ is the cut-off function. We consider two forms of \phi(x): a bounded function \phi(x) = 1 for L \leq x \leq H, and zero otherwise, and a smooth exponential function \phi(x) = \exp(-L/x - x/H). In both cases \Psi(x) has moments of arbitrary order. We show that, for \alpha > 1, P(\omega) always has a unimodal form and is peaked at \omega = 1/2, so that most probably x_1 \approx x_2. For 0 < \alpha < 1 we observe a more complicated behavior which depends on the value of \delta = L/H. In particular, for \delta < \delta_c - a certain threshold value - P(\omega) has a three-modal (for a bounded \phi(x)) and a bimodal M-shape (for an exponential \phi(x)) form which signifies that in such ensembles the wealths x_1 and x_2 are disproportionately different.Comment: 9 pages, 8 figures, to appear in Physica

Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction

BACKGROUND: There are no randomised and properly blinded trials directly comparing one PDE-5 inhibitor with another in a normal home setting. Valid indirect comparisons with a common comparator must examine equivalent doses, similar duration, similar populations, with the same outcomes reported in the same way. METHODS: Published randomised, double-blind trials of oral PDE-5 inhibitors for erectile dysfunction were sought from reference lists in previous reviews and electronic searching. Analyses of efficacy and harm were carried out for each treatment, and results compared where there was a common comparator and consistency of outcome reporting, using equivalent doses. RESULTS: Analysis was limited by differential reporting of outcomes. Sildenafil trials were clinically and geographically more diverse. Tadalafil and vardenafil trials tended to use enriched enrolment. Using all trials, the three interventions were similar for consistently reported efficacy outcomes. Rates of successful intercourse for sildenafil, tadalafil and vardenafil were 65%, 62%, and 59%, with placebo rates of 23–28%. The rates of improved erections were 76%, 75% and 71%, respectively, with placebo rates of 22–24%, and NNTs of 1.9 or 2.0. Reporting of withdrawals was less consistent, but all-cause withdrawals for sildenafil, tadalafil and vardenafil were 8% 13% and 20%. All three drugs were well tolerated, with headache being the most commonly reported event at 13–17%. There were few serious adverse events. CONCLUSION: There were differences between trials in outcomes reported, limiting comparisons, and the most useful outcomes were not reported. For common outcomes there was similar efficacy between PDE-5 inhibitors

Cell tracking in cardiac repair: what to image and how to image

Stem cell therapies hold the great promise and interest for cardiac regeneration among scientists, clinicians and patients. However, advancement and distillation of a standard treatment regimen are not yet finalised. Into this breach step recent developments in the imaging biosciences. Thus far, these technical and protocol refinements have played a critical role not only in the evaluation of the recovery of cardiac function but also in providing important insights into the mechanism of action of stem cells. Molecular imaging, in its many forms, has rapidly become a necessary tool for the validation and optimisation of stem cell engrafting strategies in preclinical studies. These include a suite of radionuclide, magnetic resonance and optical imaging strategies to evaluate non-invasively the fate of transplanted cells. In this review, we highlight the state-of-the-art of the various imaging techniques for cardiac stem cell presenting the strengths and limitations of each approach, with a particular focus on clinical applicability

Reliability of school surveys in estimating geographic variation in malaria transmission in the western Kenyan highlands.

Contains fulltext : 125827.pdf (publisher's version ) (Open Access

Effect of Ultrasonic, Microwave and Combined Microwave–Ultrasonic Pretreatment of Municipal Sludge on Anaerobic Digester Performance

Anaerobic digestion is one of the most effective means for the stabilisation of sludge. However, it has a very slow rate-limiting hydrolysis phase which is attributed to the low biodegradability of cell walls and the presence of extracellular biopolymers. This study aims at investigating the effect of ultrasonic, microwave and combined microwave–ultrasonic treatment on biogas production, solids removal and dewaterability of anaerobically digested sludge. A comparison was made between the three pretreatment techniques conducting the digestion tests under similar conditions on the same synthetic sludge sample inoculated by digested sewage sludge. The experimental results depict that the combined microwave–ultrasonic treatment (2,450-MHz, 800-W and 3-min microwave treatment followed by 0.4-W/ml and 10-min ultrasonication) resulted in better digester performance than ultrasonic or microwave treatment. Mesophilic digestion of combined microwave–ultrasonic-pretreated sludge produced a significantly higher amount of methane (147 ml) after a sludge retention time of 17 days, whereas the ultrasonic- and microwave-treated sludge samples produced 30 and 16 ml of methane, respectively. The combined microwave–ultrasonic treatment resulted in total solids reduction of 56.8 % and volatile solid removal of 66.8 %. Furthermore, this combined treatment improved dewaterability of the digested sludge by reducing the capillary suction time (CST) down to 92 s, as compared to CST of 331 s for microwave-treated and 285 s for ultrasonically treated digested sludge samples. Optimisation tests were also carried out to determine the best combination